Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023

SELL
$112.47 - $130.98 $3,599 - $4,191
-32 Reduced 48.48%
34 $4,000
Q1 2023

May 01, 2023

BUY
$104.0 - $122.92 $3,328 - $3,933
32 Added 94.12%
66 $7,000
Q4 2022

Feb 06, 2023

BUY
$84.98 - $122.67 $2,889 - $4,170
34 New
34 $3,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $33.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track New Square Capital LLC Portfolio

Follow New Square Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Square Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Square Capital LLC with notifications on news.